48 results
8-K
EX-99.1
DYAI
Dyadic International Inc., DE
14 May 24
Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
4:47pm
regulations and environmental, social and governance issues; and (x) intellectual property risks. For a more complete description of the risks that could cause
8-K
EX-99.1
DYAI
Dyadic International Inc., DE
28 Mar 24
Dyadic Reports 2023 Full Year Results and Recent Company Progress
4:07pm
and governance issues; and (x) intellectual property risks.
For a more complete description of the risks that could cause our actual results to differ
8-K
EX-99.2
vb2qi
28 Mar 24
Dyadic Reports 2023 Full Year Results and Recent Company Progress
4:07pm
8-K
EX-10.1
whp3389k6f8raxb c4cy
12 Apr 23
Dyadic Announces Expanded Licensing Agreement to Develop and Commercialize Vaccines and Biologics for African Continent
8:30am
8-K
EX-10.1
d3wj8533r gd
17 Dec 21
Dyadic Announces Research, License and Collaboration Agreement with Janssen
7:10am
10-K
gbvkfa
27 Mar 19
Annual report
4:30pm
10-12G/A
2rfxkqhd
8 Feb 19
Registration of securities (amended)
5:26pm
10-12G
i61di79 2vkjj
14 Jan 19
Registration of securities
5:23pm